PetMed Express, Inc..
PETS.US | Retail sale of pharmaceutical and medical goods, cosmetic and toilet articles in specialized stores
PetMed Express, Inc., also known as 1-800-PetMeds, is a leading pet pharmacy in the United States. The company markets and sells prescription and non-prescription pet medications, health products, and supplies for dogs, cats, and horses. Their offerings include medications for flea and tick control,...Show More
Better Health for All
30
PetMed Express, Inc. (PetMeds) is entirely devoted to pet health improvement, offering a wide range of prescription and non-prescription medications, food, supplements, and wellness essentials for dogs, cats, and horses.
1
There is no evidence of products having negative health outcomes. The company aims to make pet care more affordable through a tiered pricing strategy, private label products, discounted pet insurance via Pumpkin Insurance, and discounted employee pet care solutions through PetAssure.
2
Partnerships with Wagmo offer exclusive savings and a $25 credit, while the myBalto Foundation provides financial support for emergency vet bills, including a 25% discount to donors.
3
PetMeds and its partners reach a broad audience across the United States, including approximately 129 million Americans without easy access to pet care, and specifically target pet families in need of critical veterinary care.
4
The company actively promotes preventative health by offering heartworm and flea/tick preventatives, supplements, nutrition products, and telehealth services via VetLive and Dutch.
5
PetMeds ensures the authenticity and safety of medications through rigorous quality control and offers premium and veterinary prescription diets.
6
The company invests in health literacy by providing pet education content on its websites and through a Veterinary Advisory Board.
7
PetMeds supports the healthcare workforce by employing licensed pharmacists in all 50 states and collaborating with veterinarians.
8
Fair Money & Economic Opportunity
0
PetMed Express, Inc. operates as a pet pharmacy, selling medications and supplies. The company does not offer lending, deposit, or other financial services to consumers.
1
Therefore, all KPIs related to fair money and economic opportunity, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth-building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion for financial services, and product simplicity for financial products, are not applicable to its core business model.
2
The provided articles do not contain any information relevant to these financial services-specific metrics.
3
Fair Pay & Worker Respect
0
No evidence available to assess PetMed Express, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific, concrete data points regarding fair trade certifications, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in contracts, materials risk index, or supplier diversity spend were found in the provided articles.
1
The articles primarily consist of an executive change announcement and codes of business conduct, which do not contain quantitative performance metrics related to ethical sourcing.
2
Honest & Fair Business
0
No evidence available to assess PetMed Express, Inc. on Honest & Fair Business.
Kind to Animals
0
No evidence available to assess PetMed Express, Inc. on Kind to Animals.
No War, No Weapons
0
The provided articles do not contain any specific, quantitative data points or verifiable facts relevant to the 'No War, No Weapons' ethical value for PETS.US. While one article notes a 'low controversy level (0.9)' in 'Controversial Weapons' and indicates 'no significant involvement in the production or sale of controversial weapons,' this is a qualitative assessment and does not provide the concrete, verifiable data required to score any specific KPI according to the rubric's quantitative thresholds, such as percentages of revenue, investment ratios, or verified zero exposure.
1
Planet-Friendly Business
-40
PetMed Express, Inc. has publicly committed to the Science Based Targets initiative (SBTi) and set Scope 1 and 2 emissions reduction targets of 23% by 2030, using a 2021 baseline, which are aligned with limiting global warming to well below 2°C.
1
In 2023, the company achieved a 15.6% annual reduction in plastic packaging and a 38.2 metric ton reduction in CO2 emissions.
2
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles to assess PetMed Express, Inc. against any of the KPIs for the 'Respect for Cultures & Communities' value. The articles either explicitly state a lack of data for these metrics or do not contain any relevant information regarding community engagement, cultural impact, local employment ratios (specifically recruitment from local communities), or related policies and actions.
1
Safe & Smart Tech
0
The company's privacy policy, last updated February 13, 2024, states that users can opt out of email communications and some data collection, and describes specific data access and deletion capabilities.
1
It also mentions password protection and alternative authentication methods like Touch ID/Face ID.
2
Encryption is noted for payment processing.
3
The company adheres to PCI-DSS compliance, with auditors assessing related security practices, and emphasizes compliance with U.S. law, including CCPA and Nevada law.
4
There are no documented incidents of unauthorized data use.
Zero Waste & Sustainable Products
-20
PetMed Express, Inc. utilizes packaging that is, on average, 74% recyclable, including 85% for cardboard boxes, 65% for protective padding, and 72% for shipping envelopes.
1
The company has achieved a 15.6% reduction in plastic.
2
For hazardous waste management, PetMed Express maintains a 98.5% compliance rate for hazardous material handling and a 99.7% compliance rate for pharmaceutical waste disposal.
3